Filing Details

Accession Number:
0001209191-21-049804
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-04 20:05:10
Reporting Period:
2021-08-02
Accepted Time:
2021-08-04 20:05:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753537 G John Houston C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-02 45,922 $16.00 873,565 No 4 M Direct
Common Stock Disposition 2021-08-02 25,143 $96.96 848,422 No 4 S Direct
Common Stock Disposition 2021-08-02 6,992 $97.66 841,430 No 4 S Direct
Common Stock Disposition 2021-08-02 7,600 $98.86 833,830 No 4 S Direct
Common Stock Disposition 2021-08-02 3,441 $99.96 830,389 No 4 S Direct
Common Stock Disposition 2021-08-02 2,746 $100.66 827,643 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-08-02 45,922 $0.00 45,922 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,228 2028-09-25 No 4 M Direct
Footnotes
  1. The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.39 to $97.35, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (3).
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.39 to $97.97, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (4).
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.435 to $99.38, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (5).
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.45 to $100.375, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (6).
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.450 to $100.92, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (7).
  8. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 5, 2018, with the remainder of the shares vesting in equal monthly installments following January 5, 2018 through January 5, 2021.